UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness, population-level effects, and heath economics of measles and rubella vaccination

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2013-09, Vol.56 (9), p.1260-1269

2013

Volltextzugriff (PDF)

Effektivität, Populationseffekte und Gesundheitsökonomie der Impfungen gegen Masern und Röteln

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2013-09, Vol.56 (9), p.1260-1269

2013

Volltextzugriff (PDF)

Gesundheitsökonomische Evaluation von Impfungen

Gesundheitsökonomie & Qualitätsmanagement, 2015-08, Vol.20 (4), p.163-172

2015

Volltextzugriff (PDF)

Economic Evaluations of Varicella and Herpes Zoster Vaccination Programmes: A Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A358-A358

2013

Volltextzugriff (PDF)

Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio

Value in health, 2013-11, Vol.16 (7), p.A357-A357

2013

Volltextzugriff (PDF)

Epidemiology and Costs of Varicella and Herpes Zoster in Germany

Value in health, 2014-11, Vol.17 (7), p.A670-A671

2014

Volltextzugriff (PDF)

PIN51 Health Economic Evaluation of the Vaccination Against Herpes Zoster and Postherpetic Neuralgia in Germany

Value in health, 2012-11, Vol.15 (7), p.A394-A394

2012

Volltextzugriff (PDF)

Cost-Effectiveness of Childhood Rotavirus Vaccination in Germany

Value in health, 2013-11, Vol.16 (7), p.A351-A351

2013

Volltextzugriff (PDF)

Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop

Value in health, 2014-11, Vol.17 (7), p.A552-A552

2014

Volltextzugriff (PDF)

EE287 Epidemiologic and Economic Impact of COVID-19 Vaccination Among at-Risk Individuals and Individuals Aged ≥60 Years in Germany

Value in health, 2023-12, Vol.26 (12), p.S106

2023

Volltextzugriff (PDF)

PIH15 Estimating Herpes Zoster Disease Burden in Germany

Value in health, 2011, Vol.14 (7), p.A400-A400

2011

Volltextzugriff (PDF)

EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany

Value in health, 2022-12, Vol.25 (12), p.S215-S215

2022

Volltextzugriff (PDF)

PRM33 - HUMAN CAPITAL VS. FRICTION COST APPROACH – DIFFERENCES IN THE PRESENCE OF DEATH AND LONG-TERM CONSEQUENCES

Value in health, 2018-10, Vol.21, p.S361-S361

2018

Volltextzugriff (PDF)

PIN126 - THE QUALITY OF LIFE (QOL) LOSS ASSOCIATED WITH INVASIVE MENNINGOCOCCAL B DISEASE (MENB) IN GERMANY

Value in health, 2018-10, Vol.21, p.S242-S242

2018

Volltextzugriff (PDF)

PRO48 Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease

Value in health, 2020-12, Vol.23, p.S698-S698

2020

Volltextzugriff (PDF)

P65 Health Care Resource Utilization and Potential Disease Deterioration After Herpes Zoster Incidence in Patients with Underlying Conditions: A Retrospective Cohort Study Based on German Claims Data, 2007-2018

Value in health, 2022-01, Vol.25 (1), p.S14-S15

2022

Volltextzugriff (PDF)

EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance

Value in health, 2022-12, Vol.25 (12), p.S68-S69

2022

Volltextzugriff (PDF)

Considering Evidence From Health Economics Within Immunization Decision-Making - A Semi Multiple Criteria Decision Approach Using The Decide Tool

Value in health, 2015-11, Vol.18 (7), p.A575-A575

2015

Volltextzugriff (PDF)

PHP354 - Considering Evidence From Health Economics Within Immunization Decision-Making - A Semi Multiple Criteria Decision Approach Using The Decide Tool

Value in health, 2015-11, Vol.18 (7), p.A575-A575

2015

Volltextzugriff (PDF)

Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany

The European journal of health economics, 2013-12, Vol.14 (6), p.1015-1026

2013

Volltextzugriff (PDF)

Use of Biologic Therapies in the Treatment of Asthma - A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation

Journal of asthma and allergy, 2022-04, Vol.15, p.407-418

2022

Volltextzugriff (PDF)

Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany

Value in health, 2015-11, Vol.18 (7), p.A569-A569

2015

Volltextzugriff (PDF)

PHP320 - Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany

Value in health, 2015-11, Vol.18 (7), p.A569-A569

2015

Volltextzugriff (PDF)

A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

Value in health, 2016-11, Vol.19 (7), p.A419-A419

2016

Volltextzugriff (PDF)

PIN69 - A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

Value in health, 2016-11, Vol.19 (7), p.A419-A419

2016

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(154)

Publikationsform

Artikel
(114)
Buchkapitel
(71)
Reviews
(1)

Sprache

Englisch
(153)
Deutsch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Technology
(71)
Computer Science
(70)
Computer Science, Information Systems
(70)
Computer Science, Theory & Methods
(70)
Humans
(36)
Life Sciences & Biomedicine
(34)
Animals
(18)
Internal Medicine
(15)
Male
(13)
Female
(11)
Adult
(10)
Middle Aged
(9)
Pharmacology & Pharmacy
(9)
Biological And Medical Sciences
(8)
Chemistry
(8)
Physical Sciences
(8)
Tumor Metabolism
(8)
Chemistry, Medicinal
(7)
Classification
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness, population-level effects, and heath economics of measles and rubella vaccination

Effektivität, Populationseffekte und Gesundheitsökonomie der Impfungen gegen Masern und Röteln

Gesundheitsökonomische Evaluation von Impfungen

Economic Evaluations of Varicella and Herpes Zoster Vaccination Programmes: A Systematic Review

Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio

Epidemiology and Costs of Varicella and Herpes Zoster in Germany

PIN51 Health Economic Evaluation of the Vaccination Against Herpes Zoster and Postherpetic Neuralgia in Germany

Cost-Effectiveness of Childhood Rotavirus Vaccination in Germany

Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop

EE287 Epidemiologic and Economic Impact of COVID-19 Vaccination Among at-Risk Individuals and Individuals Aged ≥60 Years in Germany

PIH15 Estimating Herpes Zoster Disease Burden in Germany

EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany

PRM33 - HUMAN CAPITAL VS. FRICTION COST APPROACH – DIFFERENCES IN THE PRESENCE OF DEATH AND LONG-TERM CONSEQUENCES

PIN126 - THE QUALITY OF LIFE (QOL) LOSS ASSOCIATED WITH INVASIVE MENNINGOCOCCAL B DISEASE (MENB) IN GERMANY

PRO48 Health Economic Evaluation of a Routine Neisseria Meningitidis Serogroup B (MENB) Infant-Vaccination in Germany - Prevention of an Uncommon but Severe Disease

P65 Health Care Resource Utilization and Potential Disease Deterioration After Herpes Zoster Incidence in Patients with Underlying Conditions: A Retrospective Cohort Study Based on German Claims Data, 2007-2018

EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance

Considering Evidence From Health Economics Within Immunization Decision-Making - A Semi Multiple Criteria Decision Approach Using The Decide Tool

PHP354 - Considering Evidence From Health Economics Within Immunization Decision-Making - A Semi Multiple Criteria Decision Approach Using The Decide Tool

Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany

Use of Biologic Therapies in the Treatment of Asthma - A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation

Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany

PHP320 - Health Economics In Immunization Decision-Making – Results From A Systematic Literature Research and A Stakeholder Symposium In Germany

A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

PIN69 - A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

Suchergebnisse filtern